Myelinoclastic diffuse sclerosis (Schilder's disease) is immunologically distinct from multiple sclerosis: results from retrospective analysis of 92 lumbar punctures.

J Neuroinflammation · 2019 · PMC6396538 · PMID 30819213

Europe PMC DOI

hedged sentences

0.6500

closest p · 13.0× alpha

0.6500

boldest claim

The sentences

did not reach statistical significancep = 0.65not close (p > 0.1)

The frequency of OCBs was slightly lower in the adult onset subgroup (18%; N = 11) than in the childhood onset subgroup (29%; N = 24), but the difference did not reach statistical significance ( p = 0.65).

also in 111,027 other papers

highly significantno p-value reported

Schilder considered this difference highly significant (“ ein sehr wesentliche[r Unterschied] [...] [zur] gewöhnlichen Multiplen Sklerose ”).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.